Regulation
RapidAI, a health tech company specializing in stroke imaging, has received clearance from the FDA for its Rapid ASPECTS neuroimaging analysis device.
Cochlear Limited announced yesterday the U.
The new devices can link to the MyMerlinPulse app and give doctors information about a patient's heart health.
The AI tool can now be used to triage radiology scans with intracranial bleeds, mass effect, midline shift, and cranial fractures.
The device monitors vitals from up to four feet away, and is designed for use in healthcare settings or at home.
The long-awaited decision is the first regulatory authorization for Akili, and the first game-based therapeutic that the FDA has greenlit for any condition.
The system is able to continuously transmit glucose data every minute.
The company also announced its plans to launch Lumify, a handheld ultrasound device, in Japan.
Eko's ECG low ejection fraction tool will now be able to help clinicians spot cardiac complications associated with the novel coronavirus.
This news means that the Australian company will be able to expand to the United States.